DTIL PRECISION BIOSCIENCES INC
Nasdaq · SEC CIK 1357874 · EDGAR
- Bought, last 12 months
- $47.1K 4 purchases by 3 insiders
- Sold, last 12 months
- $466.2K 11 sales by 4 insiders
- Filings on record
- 162 since 2021-10-19, latest 2026-06-05 07:39
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Amoroso Michael | Pres, CEO, Dir | — | $246.2K |
| Kelly John Alexander | CFO | — | $101.1K |
| SMITH J. JEFFERSON | Chief Research Off | — | $60.0K |
| Scimeca Dario | GC, Sec | — | $58.9K |
| Frankel Stanley | Dir | $26.1K | — |
| Germano Geno J | Dir | $14.2K | — |
| Brown Melinda | Dir | $6,864 | — |
| Pire Shari Lisa | Dir | — | — |
| Buehler Kevin | Dir | — | — |
Transactions 151
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-23 | 2024-01-22 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $0.36 | -21.3K | 151.0K | -12% | -$7,663 |
| D | 2024-01-23 | 2024-01-22 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $0.36 | -137.4K | 356.4K | -28% | -$49.5K |
| D | 2024-01-23 | 2024-01-20 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +266.7K | 493.8K | +117% | — |
| D | 2024-01-23 | 2024-01-20 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +116.7K | 614.2K | +23% | — |
| D | 2023-11-06 | 2023-11-03 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $0.4 | -16.0K | 113.0K | -12% | -$6,409 |
| D | 2023-11-06 | 2023-11-02 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +55.1K | 129.0K | +75% | — |
| D | 2023-11-06 | 2023-11-02 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +108.2K | 497.5K | +28% | — |
| D | 2023-11-06 | 2023-11-02 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +283.4K | 352.1K | +412% | — |
| D | 2023-11-06 | 2023-11-03 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $0.4 | -125.0K | 227.1K | -36% | -$50.0K |
| A | 2023-10-27 | 2023-08-18 | DTIL | Kelly John Alexander | CFO | P - Purchase | $0.48 | +90.0K | 383.3K | +31% | +$43.2K |
| 2023-09-05 | 2023-08-31 | DTIL | Scimeca Dario | GC, Sec | A - Grant | $0.39 | +5,443 | 73.9K | +8% | +$2,123 | |
| 2023-09-05 | 2023-08-31 | DTIL | Kelly John Alexander | CFO | A - Grant | $0.39 | +5,951 | 389.3K | +2% | +$2,321 | |
| 2023-09-05 | 2023-08-31 | DTIL | SMITH J. JEFFERSON | Chief Research Off | A - Grant | $0.39 | +5,175 | 1.94M | +0.3% | +$2,018 | |
| 2023-08-22 | 2023-08-18 | DTIL | Kelly John Alexander | CFO | A - Grant | $0.48 | +90.0K | 383.3K | +31% | +$43.2K | |
| D | 2023-06-09 | 2023-06-07 | DTIL | Barton Shane | VP, Corp. Ctrl | M - OptEx | — | +6,060 | 27.5K | +28% | — |
| DM | 2023-06-09 | 2023-06-07 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +31.8K | 81.8K | +63% | — |
| D | 2023-06-09 | 2023-06-08 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $0.75 | -13.4K | 68.5K | -16% | -$10.0K |
| D | 2023-06-09 | 2023-06-07 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +4,872 | 1.94M | +0.3% | — |
| DM | 2023-06-09 | 2023-06-07 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +47.7K | 279.7K | +21% | — |
| D | 2023-04-28 | 2023-04-27 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $0.79 | -7,771 | 56.5K | -12% | -$6,139 |
| D | 2023-04-28 | 2023-04-26 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +26.0K | 64.3K | +68% | — |
| D | 2023-04-13 | 2023-04-11 | DTIL | Buehler Kevin | Dir | M - OptEx | — | +5,701 | 5,701 | New | — |
| D | 2023-03-23 | 2023-03-22 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $0.82 | -47.0K | 68.7K | -41% | -$38.5K |
| D | 2023-03-23 | 2023-03-21 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +102.5K | 115.7K | +777% | — |
| 2023-03-21 | 2023-03-17 | DTIL | Kelly John Alexander | CFO | P - Purchase | $0.86 | +20.0K | 245.6K | +9% | +$17.2K | |
| D | 2023-03-07 | 2023-03-03 | DTIL | Barton Shane | VP, Corp. Ctrl | M - OptEx | — | +12.7K | 21.4K | +146% | — |
| D | 2023-03-07 | 2023-03-03 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +29.5K | 47.7K | +161% | — |
| D | 2023-03-07 | 2023-03-06 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $1.07 | -9,473 | 38.2K | -20% | -$10.1K |
| D | 2023-03-07 | 2023-03-03 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +15.6K | 1.93M | +0.8% | — |
| D | 2023-03-07 | 2023-02-28 | DTIL | SMITH J. JEFFERSON | Chief Research Off | A - Grant | $0.95 | +12.2K | 1.91M | +0.6% | +$11.5K |
| D | 2023-03-07 | 2023-03-03 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +51.1K | 225.6K | +29% | — |
| D | 2023-03-07 | 2023-02-28 | DTIL | Kelly John Alexander | CFO | A - Grant | $0.95 | +11.6K | 174.5K | +7% | +$11.0K |
| D | 2023-03-07 | 2023-03-03 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +27.6K | 62.2K | +79% | — |
| D | 2023-03-07 | 2023-02-28 | DTIL | Scimeca Dario | GC, Sec | A - Grant | $0.95 | +2,163 | 34.7K | +7% | +$2,055 |
| D | 2023-03-07 | 2023-03-06 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $1.07 | -12.2K | 50.1K | -20% | -$13.0K |
| D | 2022-10-18 | 2022-10-15 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +24.2K | 24.2K | New | — |
| D | 2022-10-18 | 2022-10-17 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $1.32 | -11.0K | 13.2K | -45% | -$14.5K |
| M | 2022-09-26 | 2022-09-22+ | DTIL | Kelly John Alexander | CFO | P - Purchase | $1.32 | +45.2K | 154.7K | +41% | +$59.7K |
| 2022-06-24 | 2022-06-22 | DTIL | Kelly John Alexander | CFO | P - Purchase | $1.50 | +33.8K | 117.7K | +40% | +$50.7K | |
| DM | 2022-06-09 | 2022-06-07 | DTIL | JANTZ DEREK | CSO, Dir | M - OptEx | — | +41.7K | 4.06M | +1% | — |
| D | 2022-06-09 | 2022-06-08 | DTIL | JANTZ DEREK | CSO, Dir | S - Sale+OE | $2.06 | -18.8K | 4.06M | -0.5% | -$38.8K |
| DM | 2022-06-09 | 2022-06-07 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +47.7K | 83.9K | +132% | — |
| DM | 2022-06-09 | 2022-06-07 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +31.8K | 33.3K | +2,082% | — |
| D | 2022-06-09 | 2022-06-08 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $2.06 | -9,833 | 32.5K | -23% | -$20.3K |
| D | 2022-06-09 | 2022-06-07 | DTIL | Barton Shane | VP, Corp. Ctrl | M - OptEx | — | +6,061 | 8,720 | +228% | — |
| D | 2022-04-28 | 2022-04-26 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +26.0K | 26.0K | New | — |
| D | 2022-04-28 | 2022-04-27 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $2.10 | -7,775 | 18.3K | -30% | -$16.3K |
| 2022-03-21 | 2022-03-17 | DTIL | Kelly John Alexander | CFO | P - Purchase | $3.08 | +16.7K | 36.2K | +85% | +$51.4K | |
| DM | 2022-03-07 | 2021-08-31+ | DTIL | Kelly John Alexander | CFO | A - Grant | $5.51 | +3,712 | 19.5K | +23% | +$20.5K |
| DM | 2022-03-07 | 2021-02-26+ | DTIL | Barton Shane | VP, Corp. Ctrl | A - Grant | $5.70 | +2,659 | 2,659 | New | +$15.2K |
| DM | 2022-03-07 | 2020-02-28+ | DTIL | Scimeca Dario | GC, Sec | A - Grant | $4.98 | +10.6K | 7,976 | New | +$52.7K |
Purchase Sale Sale after option exercise All abbreviations